Ercros, S.a. · BME:ECR
Ercros — Investor Presentation (2023)
16 slides from Ercros's investor presentation, 2023
Slide 1: Pharmaceuticals division
Pharmaceuticals division
Slide 2: Key data from the pharmaceuticals division. Financial year 2022
Key data from the pharmaceuticals division. Financial year 2022 218 1 65 M€ 93% Workforce Factories Sales Export 7% Of the Ercros’ 16% sales Of the Ercros’ workforce Aranjuez (Madrid) Aranjuez 2
Slide 3: Business model
Business model ▪ The activity of the pharmaceuticals division focuses on the production of raw materials and APIs (Active Pharmaceutical Ingredients), mainly antibiotics. ▪ The division also specialises in the production of active ingredients and intermediates for third parties, tailor-made for cust
Slide 4: Strengths and challenges of the division
Strengths and challenges of the division ▪ The main strengths of this business are: • Mastery of fermentation processes. • Ability to obtain sterile products for injectable use. • High degree of internationalization. • Good position as a reliable supplier. ▪ The challenges of the division are: • Mak
Slide 5: Products, applications and market share. Financial year 2022
Products, applications and market share. Financial year 2022 Products Aplications Ranking by market share Azithromycin Respiratory infections Spain Europe World Erythromycins 1st 1st - Clarithromycin Respiratory infections Fosfomycins 1st 2nd 3rd Erythromycin and salts Respiratory infections Fusidic
Slide 6: Production and installations
Production and installations 43.000 kg/year Production capacity 1 1 1 Sterile Multifunctional 2 Fermentation production and synthesis plant Intermediate plant mixing plant with 3 products plants production line 6
Slide 7: Diagram of the biological production process
Diagram of the biological production process Raw materials Intermediate processes Final products • Fusidic acid Fusidic • Sodium fusidate Derivatives Sugar raw • Diethanolamine fusidate Fermentation Extraction Oil • Ethylsuccinate Derivatives • Stearate Vegetable Erythromycin • Stolate proteins base
Slide 8: Diagram of the chemical synthesis production process
Diagram of the chemical synthesis production process Raw materials Intermediate process Final products Fosfomycin calcium Phosphorus trichloride Fosfomycin trometamol Propardylic Sterile alcohol fosfomycin Fosfomycin sodium sodium (injectable) Acid Fosfomycin olefinic PEA salt 8
Slide 9: Markets. Financial year 2022
Markets. Financial year 2022 Where do we sell? Spain Rest of the world Rest of the EU Rest of OECD 9
Slide 10: Research and development
Research and development ▪ The pharmaceuticals division has its own R+D center located in the Aranjuez factory. ▪ The main R+D projects of the division are: • New active pharmaceutical ingredients by fermentation. • Expansion of the catalog of products offered in sterile quality. 10
Slide 11: Accreditations
Accreditations ▪ Prevention management system according to ISO 45001 standard. ▪ Quality management system according to ISO 9001 standard. ▪ Environmental management system according to ISO 14001 standard. ▪ Verification of greenhouse gas (GHG) emissions according to ISO 14064 standard. ▪ Verificati
Slide 12: Programs and ratings
Programs and ratings ▪ Responsible Care: Program of good practices in sustainability by the chemical sector. ▪ Global Compact: Program promoted by the UN that contains 10 principles of action. ▪ EcoVadis: International sustainability rating (score 84/100 in 2022). ▪ Carbon Disclosure Project (CDP):
Slide 13: Fulfilment of the Sustainable Development Goals (SDGs)
Fulfilment of the Sustainable Development Goals (SDGs) ▪ In the development of its activity, Ercros contributes to the fulfilment of the 17 SDGs set in the UN 2030 Agenda, although it has a special impact on: • SDG 3: Health and well-being. • SDG 6: Clean water and sanitation. • SDG 7: Affordable an
Slide 14: Organizational structure
Organizational structure Pharmaceuticals division Commercial Aranjuez Factory Planning and control Innovation, technology and quality Human resources and legal advice Prevention and environment 14
Slide 15: Division directory
Division directory Division manager Mª Carmen Cruzado Headquarters and facility Commercial department Paseo del Deleite, s/n Manager: Óscar Méndez 28300 Aranjuez (Madrid) Tel.: +34 918 090 344 Spain E-mail: [email protected] Tel.: +34 918 090 340 E-mail: [email protected] R+D department H
Slide 16: Thank you
Thank you For more information Ercros, S.A. Paseo del Deleite, s/n 28300 Aranjuez (Madrid) Spain Tel.: +34 918 937 700 E-mail: [email protected] www.ercros.es www.linkedin.com/company/ercros/